Divi’s Laboratories: September ’21 Results Update
Moneylife Digital Team 15 November 2021
Divi’s Laboratories’ (Divi’s) stock is a testament to the fact that the markets are forward-looking in nature. Despite reporting a decent performance in the September quarter, shares of Divi’s plummeted close to 8% on 8 November 2021. Several reasons are attributed to the decline: rising input costs, logistical issues and introduction of Pfizer’s anti-COVID oral drug candidate Paxlovid,...
Archived Premium Content
This article is outside your subscription period. You can buy this article individually.
Rs 50-Rs 100 + GST
Access will be given ONLY to this article.
Already a subscriber ? Log in
IPO Review: Tarsons Products Ltd
Moneylife Digital Team 14 November 2021
Tarsons Products Ltd (TPL) makes plastic laboratory products and scientific instruments used in research on molecular biology, cell culture, genomics, proteomics, immunology, etc. It manufactures 1,700 SKUs (stock-keeping units)...
Weekly Moneylife Indices & Sector Trends
Moneylife Digital Team 12 November 2021
From 4th November to 11 November 2021, ML Small-cap Index, ML Micro-cap Index, ML Large-cap Index and ML Mid-cap Index rose 1% each. ML Mega-cap Index, the NIFTY and the Sensex ended flat.
Turbulence Ahead for the Stock Market?
R Balakrishnan, 11 November 2021
Domestic demand seems to be back now to 2019 levels. The key difference is in the excess liquidity sloshing around and also the inflation that is generally seen in the cost of living. Perhaps the official statistics are yet to catch...
Caplin Point Laboratories: September ’21 Results Update
Moneylife Digital Team 11 November 2021
Where other pharmaceuticals companies witnessed cost pressure due to rising raw materials prices, Caplin Point Laboratories (Caplin) reported a healthy quarter due to its differentiated model. To know more about its differentiated...
Free Helpline
Legal Credit